Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge

Table 5

Subgroup analyses for gender and curative effect.

		DCR	PD	Total
Male	Group 1	4	2	6	0.286	—
	Group 2	2	5	7
	Total	6	7	13
	Group 2	2	5	7	0.672	—
	Group 3	12	15	27
	Total	14	20	34
Female	Group 1	2	5	7	0.375	—
	Group 2	1	0	1
	Total	3	5	8
	Group 2	1	0	1	1.000	—
	Group 3	5	2	7
	Total	6	2	8
Total	Group 1	6	7	13	1.000	—
	Group 2	3	5	8
	Total	9	12	21
	Group 2	3	5	8	0.808	0.059
	Group 3	17	17	34
	Total	20	22	42